-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Compared with the control group without congenital heart disease (CHD), CHD patients have an increased risk of ischemic stroke (IS)
.
However, the long-term prognosis of IS, including the risk of recurrence and death of IS, is still unclear
Stroke
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, researchers patient by the Swedish National Registration Center and registration centers to determine the cause of death of all CHD patients were born in Sweden during 1930-2017
.
The researchers randomly selected 10 control groups without CHD from the general population and matched them with the birth year and gender of each CHD patient
.
The researchers followed up the study population from January 1970 to December 2017
Cumulative incidence of IS in CHD patients and controls
The study included 88,700 CHD patients (50.
6% men) and 890,450 matched controls (51.
0% men)
.
During an average follow-up of 25.
It can be seen that the risk of IS in CHD patients is 5 times higher than that in the control group
.
However, the risk of stroke recurrence and all-cause mortality in CHD patients were 34% and 47% lower than those in the control group, respectively
The risk of IS in CHD patients is 5 times higher than that in the control group
Original source:
Kok Wai Giang.
Burden of Ischemic Stroke in Patients With Congenital Heart Disease: A Nationwide, Case-Control Study in this message
